Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 12/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2924806 | 0.89 | TRPV3 (0.34) | LMNATDP1CNR1ADRA1AKDM4E | |
| SCHEMBL10496398 | 0.87 | LMNA (0.37) | LMNATDP1CNR1ADRA1AKDM4E | |
| SCHEMBL3429247 | 0.85 | ALDH1A1 (0.36) | LMNATDP1CNR1ADRA1AKDM4E | |
| SCHEMBL13519644 | 0.85 | TSHR (0.36) | LMNATDP1CNR1ADRA1AKDM4E | |
| SCHEMBL11922823 | 0.83 | ALDH1A1 (0.46) | LMNATDP1CNR1ADRA1AKDM4E | |
| SCHEMBL15896620 | 0.82 | — | — | |
| SCHEMBL13531798 | 0.81 | SLC6A4 (0.34) | TRPV3 | |
| SCHEMBL3429243 | 0.81 | KDM4E (0.34) | KDM4ETRPV3 | |
| SCHEMBL20144720 | 0.81 | ALDH1A1 (0.53) | LMNACNR1KDM4ESMN1; SMN2TSHR | |
| SCHEMBL10282636 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2782921-B1 | ORGANIC TUNGSTEN COMPLEXES | VANDERBILT CHEMICALS LLC (US) | 2018-05-02 | — | — | EP | disclosed |
| EP-2782921-A1 | ORGANIC TUNGSTEN COMPLEXES | Vanderbilt Chemicals, LLC (US) | 2014-10-01 | — | — | EP | disclosed |
| EP-2782454-A2 | SYSTEM AND PROCESS FOR CREATING MEDIUM VISCOSITY FOOD OR PERSONAL CARE PRODUCTS BY RAPID REHYDRATION | Comaker LLC (US) | 2014-10-01 | — | — | EP | disclosed |
| CN-103958536-A | Organic tungsten complexes | VANDERBILT CHEMICALS LLC | 2014-07-30 | — | — | CN | disclosed |
| US-8669386-B2 | Organic tungsten complexes | VANDEBILT CHEMICALS, LLC (US) | 2014-03-11 | — | — | US | disclosed |
| WO-2013078379-A2 | SYSTEM AND PROCESS FOR CREATING MEDIUM VISCOSITY FOOD OR PERSONAL CARE PRODUCTS BY RAPID REHYDRATION | COMAKER LLC (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013077948-A1 | ORGANIC TUNGSTEN COMPLEXES | VANDERBILT CHEMICALS, LLC. (US) | 2013-05-30 | — | — | WO | disclosed |
| US-20120165563-A1 | ORGANIC TUNGSTEN COMPLEXES | R.T. VANDERBILT COMPANY, INC. | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165563-A1 | ORGANIC TUNGSTEN COMPLEXES | ADH5, ELOVL5, ALOX5 | LMNA 4555/4885TDP1 3809/4885CNR1 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.